arrow
P

Paul Antony

L
H指数:30
被引数:3,839

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LRRK2-G2019S impairs astrocyte differentiation and triggers a senescence-like phenotype in Parkinson’s disease models

LRRK2-G2019S损害星形胶质细胞分化并在帕金森病模型中触发一种衰老样表型

2026-08-050
OAAI
Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss

帕金森病突变型Miro1导致线粒体功能障碍和多巴胺能神经元丢失

BRAIN
IF11.7
2025-09-019
OAAI
Author Correction: Mitochondria interaction networks show altered topological patterns in Parkinson’s disease

作者更正:线粒体相互作用网络在帕金森病中显示出改变的拓扑模式

2025-07-030
OA
Insulin resistance compromises midbrain organoid neuronal activity and metabolic efficiency predisposing to Parkinson's disease pathology

胰岛素抵抗损害中脑类器官神经元活动及代谢效率,易导致帕金森病病理变化

2025-01-281
OA
Modeling early phenotypes of Parkinson's disease by age-induced midbrain-striatum assembloids
2024-11-231
PRE
PARK7/DJ-1 deficiency impairs microglial activation in response to LPS-induced inflammation
2024-07-163
OAAI
Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease

在帕金森氏病线粒体亚型的患者衍生细胞中验证的多基因风险评分

2024-05-201
OA
Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates Inflammation
2022-04-2338
OA
Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state

人类中脑的单细胞测序揭示了神经胶质的激活和帕金森特异性神经元状态

BRAIN
IF11.7
2021-12-17219
OAAI
Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment
2021-10-1244
OA
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1
2021-10-0126
OAAI